Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 152

1.

Results of comprehensive diagnostic work-up in 'idiopathic' dilated cardiomyopathy.

Broch K, Andreassen AK, Hopp E, Leren TP, Scott H, Müller F, Aakhus S, Gullestad L.

Open Heart. 2015 Oct 9;2(1):e000271. doi: 10.1136/openhrt-2015-000271. eCollection 2015.

2.

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.

Hopkins PN, Defesche J, Fouchier SW, Bruckert E, Luc G, Cariou B, Sjouke B, Leren TP, Harada-Shiba M, Mabuchi H, Rabès JP, Carrié A, van Heyningen C, Carreau V, Farnier M, Teoh YP, Bourbon M, Kawashiri MA, Nohara A, Soran H, Marais AD, Tada H, Abifadel M, Boileau C, Chanu B, Katsuda S, Kishimoto I, Lambert G, Makino H, Miyamoto Y, Pichelin M, Yagi K, Yamagishi M, Zair Y, Mellis S, Yancopoulos GD, Stahl N, Mendoza J, Du Y, Hamon S, Krempf M, Swergold GD.

Circ Cardiovasc Genet. 2015 Dec;8(6):823-31. doi: 10.1161/CIRCGENETICS.115.001129. Epub 2015 Sep 15.

PMID:
26374825
3.

Mutation p.L799R in the LDLR, which affects the transmembrane domain of the LDLR, prevents membrane insertion and causes secretion of the mutant LDLR.

Strøm TB, Laerdahl JK, Leren TP.

Hum Mol Genet. 2015 Oct 15;24(20):5836-44. doi: 10.1093/hmg/ddv304. Epub 2015 Jul 28.

PMID:
26220972
4.

[Increased mortality in familial hypercholesterolemia].

Mundal L, Sarancic M, Ose L, Iversen PO, Borgan JK, Veierød MB, Leren TP, Retterstøl K.

Tidsskr Nor Laegeforen. 2015 Jun 16;135(11):1024-5. doi: 10.4045/tidsskr.15.0244. eCollection 2015 Jun 16. Norwegian. No abstract available.

5.

Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010.

Mundal L, Sarancic M, Ose L, Iversen PO, Borgan JK, Veierød MB, Leren TP, Retterstøl K.

J Am Heart Assoc. 2014 Dec 2;3(6):e001236. doi: 10.1161/JAHA.114.001236.

6.

Sorting an LDL receptor with bound PCSK9 to intracellular degradation.

Leren TP.

Atherosclerosis. 2014 Nov;237(1):76-81. doi: 10.1016/j.atherosclerosis.2014.08.038. Epub 2014 Sep 2. Review.

PMID:
25222343
7.
8.

Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2.

Christiansen M, Hedley PL, Theilade J, Stoevring B, Leren TP, Eschen O, Sørensen KM, Tybjærg-Hansen A, Ousager LB, Pedersen LN, Frikke-Schmidt R, Aidt FH, Hansen MG, Hansen J, Bloch Thomsen PE, Toft E, Henriksen FL, Bundgaard H, Jensen HK, Kanters JK.

BMC Med Genet. 2014 Mar 7;15:31. doi: 10.1186/1471-2350-15-31.

9.

Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene.

Berge KE, Retterstøl K, Romeo S, Pirazzi C, Leren TP.

Atherosclerosis. 2014 May;234(1):30-3. doi: 10.1016/j.atherosclerosis.2014.02.005. Epub 2014 Feb 18.

PMID:
24589565
10.

PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulum.

Strøm TB, Tveten K, Leren TP.

Biochem J. 2014 Jan 1;457(1):99-105. doi: 10.1042/BJ20130930.

PMID:
24144304
11.

Genetics of hypertrophic cardiomyopathy in Norway.

Berge KE, Leren TP.

Clin Genet. 2014 Oct;86(4):355-60. doi: 10.1111/cge.12286. Epub 2013 Oct 23.

PMID:
24111713
12.

Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects.

Hasselberg NE, Edvardsen T, Petri H, Berge KE, Leren TP, Bundgaard H, Haugaa KH.

Europace. 2014 Apr;16(4):563-71. doi: 10.1093/europace/eut291. Epub 2013 Sep 20.

13.

PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment.

Tveten K, Strøm TB, Berge KE, Leren TP.

J Lipid Res. 2013 Jun;54(6):1560-6. doi: 10.1194/jlr.M034371. Epub 2013 Mar 18.

14.

[Weight loss pills purchased on the internet as the cause of ventricular fibrillation].

Pareek M, Pedersen RL, Leren TP, Jensen HK.

Ugeskr Laeger. 2013 Mar 11;175(11):739-40. Danish.

PMID:
23480888
15.

Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy.

Almaas VM, Haugaa KH, Strøm EH, Scott H, Dahl CP, Leren TP, Geiran OR, Endresen K, Edvardsen T, Aakhus S, Amlie JP.

Europace. 2013 Sep;15(9):1319-27. doi: 10.1093/europace/eut028. Epub 2013 Feb 20.

16.

Mutations in the SORT1 gene are unlikely to cause autosomal dominant hypercholesterolemia.

Tveten K, Strøm TB, Cameron J, Berge KE, Leren TP.

Atherosclerosis. 2012 Dec;225(2):370-5. doi: 10.1016/j.atherosclerosis.2012.10.026. Epub 2012 Oct 11.

PMID:
23102784
17.

Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation.

Marduel M, Ouguerram K, Serre V, Bonnefont-Rousselot D, Marques-Pinheiro A, Erik Berge K, Devillers M, Luc G, Lecerf JM, Tosolini L, Erlich D, Peloso GM, Stitziel N, Nitchké P, Jaïs JP; French Research Network on ADH, Abifadel M, Kathiresan S, Leren TP, Rabès JP, Boileau C, Varret M.

Hum Mutat. 2013 Jan;34(1):83-7. doi: 10.1002/humu.22215. Epub 2012 Oct 11.

18.

The prevalence of mutations in KCNQ1, KCNH2, and SCN5A in an unselected national cohort of young sudden unexplained death cases.

Winkel BG, Larsen MK, Berge KE, Leren TP, Nissen PH, Olesen MS, Hollegaard MV, Jespersen T, Yuan L, Nielsen N, Haunsø S, Svendsen JH, Wang Y, Kristensen IB, Jensen HK, Tfelt-Hansen J, Banner J.

J Cardiovasc Electrophysiol. 2012 Oct;23(10):1092-8. doi: 10.1111/j.1540-8167.2012.02371.x. Epub 2012 Aug 6.

PMID:
22882672
19.
20.

Postmortem genetic testing of the ryanodine receptor 2 (RYR2) gene in a cohort of sudden unexplained death cases.

Larsen MK, Berge KE, Leren TP, Nissen PH, Hansen J, Kristensen IB, Banner J, Jensen HK.

Int J Legal Med. 2013 Jan;127(1):139-44. doi: 10.1007/s00414-011-0658-2. Epub 2012 Jan 6.

PMID:
22222782
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk